US 9827310
Anti-ErbB3 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9827310 (Anti-ErbB3 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/517, A61K31/5377